fda bpc 157 compounding category 2 list
fda bpc 157 compounding category 2 list Peptide Update: Removals Explained Category 1 vs. Category 2.
Category 1 vs. Category 2. The FDA's peptide update, explained. Category 2 peptides are on the FDA's difficult to compound list, which effectively blocks licensed pharmacies from producing them. Category 1 means FDA considers adding a dozen peptides to its bulk drug compounding list RAPS FDA's Overreach on Compounded Peptides Regulatory Alert: FDA's April 2026 Update on BPC 157 and GHK Cu Holt Law
USD29.72
USD77.72
Pay in 4 interest-free payments of $7.43 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
